US Trustee Targets Bonuses In Antibiotics Firm's Ch. 11
The Office of the U.S. Trustee took issue Wednesday with antibiotics developer Melinta Therapeutics Inc.'s plan to award up to about $3.3 million in employee bonuses in its Delaware Chapter 11,...To view the full article, register now.
Already a subscriber? Click here to view full article